YOUTUBE (The Hill) - Watch Now! Rethinking Psychedelic Treatment for America's Mental Health Crisis
Psychiatry is at an inflection point. And the stakes are high. Mental illness costs the U.S. economy more than $280 billion annually, drives veteran suicide rates, and places mounting strain on everything from emergency rooms to the workforce. Yet many of today’s medicines have not advanced in decades despite the rising prevalence and unmet need. For the one in five Americans living with a mental health disorder and veterans who face disproportionally high suicide rates and do not respond to conventional treatments, the gap between what medicine promises and what it delivers has never been more consequential. But change is underway. A new wave of rigorous clinical science is unlocking the therapeutic potential of psychedelic medicines…